Atypical Hemolytic Uremic Syndrome Drug Market – Addressing Rare Complement-Mediated Disease
The Atypical Hemolytic Uremic Syndrome Drug Market focuses on therapies for atypical hemolytic uremic syndrome (aHUS), a rare condition involving uncontrolled complement-system activity. It can cause destruction of red blood cells, low platelet counts, and kidney injury.
Current Market Landscape
Complement-inhibiting medicines have changed treatment options for eligible patients. Diagnosis,...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Russian
Romaian
Portuguese (Brazil)
Greek